(1)
Ameen, Z. A.; Ali, S. H. Effects of Aldosterone, Osteoprotegerin and Fibroblast Growth Factor-23 and Some Biochemical Markers in Chronic Kidney Disease Patients (Stage II-IV) Among Patients With or Without Cardiovascular Events. Iraqi Journal of Pharmaceutical Sciences 2018, 27 (2), 150-158. https://doi.org/10.31351/vol27iss2pp150-158.